EPB41L4A and nasopharyngeal carcinoma: In this study, we delineated the mechanism by which TGF-β inhibits EPB41L4A-AS2 in NPC, which showed that EPB41L4A-AS2 was reactivated after we silenced key genes in the TGF-β molecule pathway.